Summary
CME Group Inc. (CME) filed an 8-K on June 20, 2018, to report on a significant debt financing event that occurred on June 13, 2018. The company entered into an Underwriting Agreement to issue and sell a total of $1.2 billion in aggregate principal amount of senior notes. Specifically, CME Group will issue $500 million of 3.750% Notes due 2028 and $700 million of 4.150% Notes due 2048 in an underwritten public offering. This transaction is noteworthy for investors as it represents a substantial increase in the company's long-term debt. The proceeds from this offering are intended to fund the acquisition of a significant portion of the company's previously owned equity stake in CME Clearing. Investors should consider this debt issuance in the context of CME's overall capital structure and its future financing strategies. The Underwriting Agreement includes standard provisions such as representations, warranties, covenants, indemnification, and contribution rights, typical for such public debt offerings.
Key Highlights
- 1CME Group Inc. entered into an Underwriting Agreement on June 13, 2018, for a public offering of senior notes.
- 2The company is issuing $500,000,000 in aggregate principal amount of 3.750% Notes due 2028.
- 3The company is also issuing $700,000,000 in aggregate principal amount of 4.150% Notes due 2048.
- 4The total aggregate principal amount of the notes being issued is $1.2 billion.
- 5The Underwriting Agreement was made with J.P. Morgan Securities LLC, Barclays Capital Inc., and Merrill Lynch, Pierce, Fenner & Smith Incorporated as representatives of the underwriters.
- 6The agreement contains customary representations, warranties, covenants, indemnification, and contribution provisions.
- 7The filing does not explicitly state the use of proceeds, but context from prior filings or market understanding would likely indicate funding for corporate purposes, such as share repurchases or acquisitions.